Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Agent Collaborative Framework for Adverse Drug Reaction Prediction: Evidence-Based Verification and Human-Machine Decision Comparative Study

NCT07808866 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT07808866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07808866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Agent Collaborative Framework for Adverse Drug Reaction Prediction: Evidence-Based Verification and Human-Machine Decision Comparative Study
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Recruiting
Start date
June 19, 2026
Completion date
December 19, 2027
Enrollment
20,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug reactions, clinical decision support